Current data supporting that radiogenomic approach can identify epidermal growth factor receptor (EGFR) expression [59] or be utilized to help to differentiate between adenocarcinoma and squamous cell carcinoma of the lung [60] predicting diagnosis, prognosis, and optimal therapy. Here, EGFR is linked to squamous cell lung carcinoma.